Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enveric Biosciences (DE:SLZA)
FRANKFURT:SLZA
Enveric Biosciences (SLZA) Stock Price & Analysis
1 Followers
SLZA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.66 - €4.25
Previous Close€0.92
Volume0.00
Average Volume (3M)2.46K
Market Cap
€6.75M
Enterprise Value€4.63M
Total Cash (Recent Filing)$2.29M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta-0.69
Next Earnings
May 14, 2024EPS Estimate
-€1.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,294,005
10 Day Avg. Volume422
30 Day Avg. Volume2,464
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)4.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.65
Forecast
1Y Price Target
€9.28Price Target Upside906.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Enveric Biosciences News
PremiumCompany Announcements
Enveric Biosciences Explores Joint Disease Treatment Licensing
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
5.69% Other Institutional Investors
94.31% Public Companies and
Individual Investors
SLZA FAQ
What was Enveric Biosciences’s price range in the past 12 months?
Enveric Biosciences lowest stock price was €0.66 and its highest was €4.25 in the past 12 months.
What is Enveric Biosciences’s market cap?
Currently, no data Available
When is Enveric Biosciences’s upcoming earnings report date?
Enveric Biosciences’s upcoming earnings report date is May 14, 2024 which is in 25 days.
How were Enveric Biosciences’s earnings last quarter?
Enveric Biosciences released its earnings results on Mar 28, 2024. The company reported -€1.355 earnings per share for the quarter, beating the consensus estimate of -€1.466 by €0.111.
Is Enveric Biosciences overvalued?
According to Wall Street analysts Enveric Biosciences’s price is currently Undervalued.
Does Enveric Biosciences pay dividends?
Enveric Biosciences does not currently pay dividends.
What is Enveric Biosciences’s EPS estimate?
Enveric Biosciences’s EPS estimate is -€1.03.
How many shares outstanding does Enveric Biosciences have?
Currently, no data Available
What happened to Enveric Biosciences’s price movement after its last earnings report?
Enveric Biosciences reported an EPS of -€1.355 in its last earnings report, beating expectations of -€1.466. Following the earnings report the stock price went up 0.109%.
Which hedge fund is a major shareholder of Enveric Biosciences?
Currently, no hedge funds are holding shares in DE:SLZA
---
Enveric Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€9.28 (906.45% Upside)
€9.28 (906.45% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.50%
12-Months-Change
Fundamentals
Return on Equity
-187.69%
Trailing 12-Months
Asset Growth
-68.71%
Trailing 12-Months
Company Description
Enveric Biosciences
Ameri Holdings, Inc. specializes in delivering SAP cloud, digital and enterprise services to clients worldwide. Its services center around SAP and include technology consulting, business intelligence, cloud services, application development/integration and maintenance, implementation services, infrastructure services, and independent validation services, all of which can be delivered as a set of managed services or on an on-demand service basis, or a combination of both. The company was founded by Srinidhi Devanur in February 1994 and is headquartered in Suwanee, GA.
---
SLZA Stock 12 Months Forecast
Average Price Target
€9.28
▲(906.45% Upside)
Technical Analysis
Enveric Biosciences
―
Atossa Therapeutics
―
Benitec Biopharma
―
Kala Pharmaceuticals
―
Medicinova
―
Best Analysts Covering SLZA
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+25.00%
initiated a buy rating 3 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.00% per trade.
---